Table 2 FINNAKI cohort. Patient characteristics and procedure data
From: The origin of plasma neutrophil gelatinase-associated lipocalin in cardiac surgery
ALL [N = 306 (100%)] | NO-AKI [N = 238 (77.8%)] | AKI [N = 68 (22.2%)] | |
|---|---|---|---|
Age (years) | 68 (60–75) | 67 (58–74) | 71 (64–78)** |
Male gender | 221 (72.2) | 171 (77.4) | 50 (73.5) |
Co-Morbidity | |||
Insulin dependent diabetes mellitus | 25 (8.2%) | 16 (6.7%) | 9 (13%) |
Noninsulin dependent diabetes mellitus | 55 (18.0%) | 41 (17.2%) | 14 (20%) |
Hypertension | 196 (64.1%) | 146 (61.3%) | 50 (73.5%) |
Chronic Kidney Disease | 40 (13.1%) | 24 (10.0%) | 16 (23.5%)** |
Pre-operative LVEF less than 30% | 11 (3.6%) | 9 (3.8%) | 2 (2.9%) |
Surgery | |||
CABG only | 152 (49.7%) | 124 (52.1%) | 28 (41.2%) |
Valve-only | 101 (33.0%) | 79 (33.2) | 22 (32.4%) |
CABG and valve | 38 (12.4) | 24 (10.1%) | 14 (20.6%)* |
Other cardiac surgery | 9 (2.9%) | 8 (3.4%) | 1 (1.5%) |
Aortic rupture or dissection | 6 (2.0) | 3 (1.3%) | 3 (4.4%) |
Off-pump surgery | 28 (9.2%) | 26 (10.9%) | 2 (2.9%)* |
Cardiopulmonary bypass timea (min) | 103 (82–147) | 102 (81–146) | 104 (84–155)* |
Aortic cross-clamping timea (min) | 72 (57–101) | 74 (57–100) | 70 (55–113) |